Treatment of lupus-prone mice with a dual inhibitor of TLR7 and TLR9 leads to reduction of autoantibody production and amelioration of disease symptoms-Reference-Cited by-同舟云学术

Treatment of lupus-prone mice with a dual inhibitor of TLR7 and TLR9 leads to reduction of autoantibody production and amelioration of disease symptoms

Published:2007-12 Issue:12 Volume:37 Page:3582-3586
ISSN:0014-2980
Container-title:European Journal of Immunology
language:en
Short-container-title:Eur. J. Immunol.

Author:

Barrat Franck J.,Meeker Thea,Chan Jean H.,Guiducci Cristiana,Coffman Robert L.

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Reference17 articles.

1. Antibodies to DNA

2. Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy

3. Immune Interferon in the Circulation of Patients with Autoimmune Disease

4. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus

5. Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood

Cited by 249 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Animal models of systemic lupus erythematosus (SLE);Dubois' Lupus Erythematosus and Related Syndromes;2025

2. Decoding the connection between SLE and DNA Sensors: A comprehensive review;International Immunopharmacology;2024-08

3. Ro60—Roles in RNA Processing, Inflammation, and Rheumatic Autoimmune Diseases;International Journal of Molecular Sciences;2024-07-14

4. Autoimmune diseases and atherosclerotic cardiovascular disease;Nature Reviews Cardiology;2024-06-27

5. Discovery of Novel Small Molecule Dual Inhibitor Targeting Toll-Like Receptors 7 and 9;Journal of Chemical Information and Modeling;2024-06-21